Nabanita Nawar

Nabanita Nawar, PhD is the Co-Founder & CEO at HDAX Therapeutics since April 2022. Prior to this, Nabanita worked as a Lecturer at the Temerty Faculty of Medicine at the University of Toronto. Nabanita has a background in Medicinal Chemistry and Drug Design, and has experience as a PhD Candidate at the University of Toronto. Additionally, Nabanita has held positions as an Associate Editor at the Journal of Science Policy and Governance, a Scientific Consultant at Dalriada Drug Discovery, and served on committees at the Canadian Science Policy Centre. With a previous role as a Data Analyst at the National Bureau of Economic Research, Nabanita brings a wealth of experience to their current role in leading HDAX Therapeutics.